Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4 , 5 .”
From Naturally occurring p16Ink4a-positive cells shorten healthy lifespan (2016) · cites this paper as [5]
In the citing paper
“In the absence of p16, the age-related deterioration of adipose tissue, skeletal muscle and eye was attenuated193.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Importantly, genetically preventing the accumulation of p19ARF, a tumour suppressor that modulates the stability of p53 by influencing MDM2-mediated destruction, did not result in similar prevention193, indicating that p16 was critical for these disorders.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Removal of SnCs delays several pathologies7–9 and increases healthy lifespan8.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [9]
In the citing paper
“Remarkably, treated mice of both BubR1H/H;INK-ATTAC lines had substantially delayed onset of lordokyphosis (a measure of sarcopenia onset in this model15) and cataracts compared to untreated mice (Fig. 2b, c).”
From Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (2011) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“Both p16 Ink4a and p19 Arf are effectors of senescence in cultured cell”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“Recent evidence in middle-aged p16 Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor population”
Background
Cited by
Items 401–410 of 410
Millerand, M. (2020) · theses.fr (ABES) · doi:10.70675/d5e9dae6zd9d7z4a05z8fd2zf0ff4ffab0a6
L’échappement à la sénescence induite par chimiothérapie : Un nouveau rôle de la protéine AGR2
Maarouf, A. (2021) · theses.fr (ABES) · doi:10.70675/2804fda4z0d12z4a01za7eezd95a7d0b70d2
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Reverse aging through cell cycle regulation
Sheoran, P., Tripathi, R. D., Mishra, S. K., Marathe, N. K., Yadav, A., Bhardwaj, A., Singh, P., Singh, K., Tikhonova, M. A., Gopenath, T. S., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00014-x
Behavior Prediction in Signaling Networks: Modeling of p16-Mediated Pathway
Bashirov, R. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-20041-9_5
CD45+ cell-enriched scRNA-seq of human breast implant fibrotic capsule
Rindone, A. N., & Elisseeff, J. H. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20017380
Cellular Senescence and Premature Aging in Lung Diseases
Aoshiba, K., Tsuji, T., Yamaguchi, K., Itoh, M., & Nakamura, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00017-4
Metadata
- Authors
- Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., Eberhardt, N. L., Terzic, A., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2008-05-30
- Volume
- 10
- Issue
- 7
- Pages
- 825-836
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2594014
- OpenAlex
- W1982763980
- Cited by
- 408
- References
- 50
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 26 · 2021: 32 · 2020: 30 · 2019: 23 · 2018: 25 · 2017: 29 · 2016: 29 · 2015: 24 · 2014: 27 · 2013: 17 · 2012: 20
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-05-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- National Cancer Institute (R01CA096985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, p19ARF, cellular senescence, aging, tumour suppressor, skeletal muscle, adipose tissue, premature aging, checkpoint kinase 2
- MeSH terms
- Adipose Tissue, Aging, Animals, Cells, Cultured, Eye, Fibroblasts, Genotype, Humans, Male, Mice, Inbred C57BL, Neoplasms, Tissue Distribution, Biomarkers, Survival Rate, Cellular Senescence, Protein Serine-Threonine Kinases, Mice, Knockout, Muscle, Skeletal, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.